1. Lung cancer stem cells: a biological and clinical perspective

   • Ana Koren
   • Helena Motaln
   • Tanja Cufer

   Review 31 July 2013 Pages: 265 - 275

   

2. Insulin-like growth factor-1 receptor (IGF-1R) as a biomarker for resistance to the tyrosine kinase inhibitor gefitinib in non-small cell lung cancer

   • Nir Peled
   • Murry W. Wynes
   • Fred R. Hirsch

   Original Paper 26 April 2013 Pages: 277 - 288

   

3. In vitro treatment of carcinoma cell lines with pancreatic (pro)enzymes suppresses the EMT programme and promotes cell differentiation

   • Macarena Perán
   • Juan Antonio Marchal
   • David Tosh

   Original Paper 16 May 2013 Pages: 289 - 301

   

4. Biofunctional characteristics of in situ and invasive breast carcinoma

   • Sara Bravaccini
   • Anna Maria Granato
   • Dino Amadori

   Original Paper 27 June 2013 Pages: 303 - 310

5. Over-expression of Her-2 in colorectal cancer tissue, but not in serum, constitutes an independent worse prognostic factor

   • Sang-Woo Lim
   • Hye-Ran Kim
   • Myung-Geun Shin

   Original Paper 31 May 2013 Pages: 311 - 321

   

6. Promoter hypermethylation contributes to the frequent suppression of the CDK10 gene in human nasopharyngeal carcinomas

   • Yanjie You
   • Wenjun Yang
   • Yonggang Ran

   Original Paper 06 June 2013 Pages: 323 - 331

   

7. Analysis of expression of membrane-bound tumor markers in ductal carcinoma in situ of the breast: paving the way for molecular imaging

   • Jeroen F. Vermeulen
   • Elsken van der Wall
   • Paul J. van Diest

   OriginalPaper 07 June 2013 Pages: 333 - 340

   

8. Visualising and quantifying angiogenesis in metastatic colorectal cancer

   • Torben Frøstrup Hansen
   • Boye Schnack Nielsen
   • Flemming Brandt Sørensen

   Original Paper 10 July 2013 Pages: 341 - 350